A Prospective Non-Interventional Study on STRUctum® in Adult Patients with oSTeoarthritis – TRUST

A Prospective Non-Interventional Study on STRUctum® in Adult Patients with oSTeoarthritis – TRUST

Hide study title
Status
Status :
Completed
Type of study
Etude en vie réelle
Min. Age
50
Years old
Max. Age
85
Years old
Gender
All

Brief summary

Osteoarthritis or arthrosis is a disorder that can affect any joint of the body, like the knees. Osteoarthritis may result in pain, stiffness and loss of movement. Many treatments are available to reduce pain due to osteoarthritis.
Among these treatments, there are drugs termed chondroprotective. Chondroprotective drugs help protect cartilage by slowing down cartilage breakdown and helping it regenerate. They improve symptoms of osteoarthritis like pain and stiffness. Chondroitin sulfate is a natural chondroprotective substance present in the joints of the body. Structum® is a drug containing chondroitin.
To date, no real-world studies have been conducted to describe the burden associated with osteoarthritis in people treated with chondroitin. This study aims to understand how people live with knee osteoarthritis and how chondroitin sulfate may help improve their daily life.

Therapeutic area :
Rhumatology
Disease :
Arthrosis
Study medication :
Structum®
Phase : Etude en vie réelle
Start Date :
July 2023
End Date / study Completion Date :
October 28, 2024
Study ID : NIS13559
CT.gov Number : NCT06623773
Countries :
Poland

Access to Lay Protocol Synopsis

A summary of the protocol written in plain language and describing the objectives of the study is provided.

Send by email